文献速递精神分裂症与精神病性障碍会诊联络精神医学

抗胆碱负荷与多基因交互对精神病谱系认知及脑结构的影响

Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders.
PubMed 文献 · Am J Psychiatry · 2025-05-28

该研究基于B-SNIP联盟1704例精神病谱系障碍患者,发现抗胆碱负荷越高,BACS认知 composite 评分越低、全脑灰质体积越小;认知多基因评分较高者抗胆碱负荷对认知的不良影响更明显,而精神科多基因复合评分较低者抗胆碱负荷相关的灰质体积减少更显著。灰质体积减少部分介导了抗胆碱负荷与认知损害的关联,且该中介受精神科多基因复合评分调节。

要点

  • 抗胆碱负荷越高,精神病谱系患者BACS认知评分越低、全脑灰质体积越小。
  • 认知多基因评分较高者,抗胆碱负荷对认知的不良影响更明显。
  • 精神科多基因复合评分较低者,抗胆碱负荷相关灰质体积减少更显著。

核心结论

  • 抗胆碱负荷与多基因交互显著影响精神病谱系患者的认知和脑结构,提示新的基因-环境交互机制。

研究设计与样本

  • 研究纳入B-SNIP联盟1704例18-65岁、多祖先的精神病谱系障碍患者,进行认知评估、结构神经影像、基因分型和全面药物审查。
  • 采用线性回归模型检验抗胆碱负荷与多基因评分的交互及与认知和脑结构结局的关联,并校正临床协变量和FDR多重检验。
  • 使用假设驱动的调节中介模型探索潜在关联路径。

主要发现

  • 较高的抗胆碱负荷与较低的BACS composite 评分和较小的全脑灰质体积显著相关。
  • 认知多基因评分较高的个体,抗胆碱负荷对BACS评分的不良影响更大。
  • 精神科多基因复合评分较低的个体,抗胆碱负荷相关的全脑灰质体积减少更明显。
  • 抗胆碱负荷与认知损害的关联部分由全脑灰质体积减少中介,并受精神科多基因复合评分调节。

关键数值与推荐

  • 主要认知结局为BACS composite 评分,主要脑结构表型为全脑灰质体积。
  • 抗胆碱负荷评分使用CRIDECO Anticholinergic Load Scale对定期用药进行量化。
  • 构建认知、精神分裂症、双相障碍和抑郁的多基因评分,并生成精神科多基因复合评分。

临床怎么用

  • 对精神病谱系患者评估用药抗胆碱负荷,尤其关注认知多基因评分较高者的认知风险。
  • 在解释抗胆碱负荷相关灰质体积变化时,可考虑精神科多基因复合评分的调节作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to determine whether genetic predispositions to cognitive ability or psychiatric conditions interact with anticholinergic burden (AChB) to impact cognition and brain structure in individuals with psychotic disorders. METHODS: Participants with psychosis spectrum disorders (N=1,704) from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) consortium, 18-65 years of age and representing diverse ancestries, underwent cognitive assessments, structural neuroimaging, genotyping, and a comprehensive medication review. The primary cognitive outcome was the Brief Assessment of Cognition in Schizophrenia (BACS) composite score, and the primary brain structural phenotype was total gray matter volume. AChB scores for scheduled medications were quantified using the CRIDECO Anticholinergic Load Scale. Polygenic scores (PGSs) for cognition, schizophrenia, bipolar disorder, and depression were constructed, and a composite psychiatric PGS was subsequently generated. Linear regression models were used to examine AChB-PGS interactions and their associations with cognitive and brain structure outcomes, adjusting for clinical covariates and multiple testing with false discovery rate. Hypothesis-driven moderated mediation models were used to explore potential association pathways. RESULTS: Higher AChB was significantly associated with lower BACS performance and reduced gray matter volume. Individuals with higher cognitive PGS values exhibited greater adverse effects of AChB on BACS, while those with lower composite psychiatric PGS values showed more pronounced gray matter volume reductions from AChB. AChB associations with cognitive impairment were partially mediated by reduced gray matter volume and were moderated by composite psychiatric PGS. CONCLUSIONS: Anticholinergic-polygenic interactions significantly impact cognition and brain structure in individuals with psychotic disorders, highlighting a novel gene-by-environment interaction that advances our mechanistic understanding of cognitive impairments in this population.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang L, Ivleva EI, Parker DA, et al. Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders. Am J Psychiatry. 2025. PMID: 40432343. doi:10.1176/appi.ajp.20240709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。